Sterling Capital Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
Sterling Capital Management's CDNA Position: Q2 2026 in Review
Sterling Capital Management reduced its CareDx (CDNA) stake by 45% in Q2 2026, selling an estimated $3.2K and leaving 180 shares worth $5.13K. The position accounts for ﹤0.01% of the portfolio, ranked #2600.
Sterling Capital Management first reported a position in CDNA in Q4 2016 and has held it in 10 quarters since. The position peaked at $32K in Q4 2016. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Sterling Capital Management held 180 shares of CareDx worth $5.13K as of Q2 2026.
- Sterling Capital Management sold 147 CareDx shares in Q2 2026, an estimated $3.2K.
- CareDx made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2600 holding.
- Sterling Capital Management first reported a position in CareDx in Q4 2016 and has held it in 10 quarters since.
- Sterling Capital Management's CareDx position peaked at $32K in Q4 2016.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.